A Study to Evaluate Glucose and Insulin Response to Nutralin
Completed
- Conditions
- Diabetes
- Interventions
- Dietary Supplement: Nutralin
- Registration Number
- NCT01275820
- Lead Sponsor
- Avera McKennan Hospital & University Health Center
- Brief Summary
The purpose of this study is to evaluate how an investigational food product affects a healthy person's blood sugar and insulin levels.
- Detailed Description
The investigational food product has helped decrease the amount of insulin needed in treating diabetic dogs and has improved the dogs' longevity and quality of life. Observational analysis by trained veterinarians has indicated that the natural fluctuations in blood glucose levels do not exist in dogs using the product. The hypothesis for this study is that healthy human subjects will have an increase in insulin levels after consuming the investigational food product.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- Men and women who are at least 18 years of age
- Non-diabetic
Exclusion Criteria
- Diabetes
- Women who are pregnant, breastfeeding or planning to become pregnant
- Current and active liver or kidney disease
- Any food allergies
- Celiac disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Nutralin Nutralin All 10 subjects in the study will consume the investigational food product.
- Primary Outcome Measures
Name Time Method Glucose blood level 4 weeks Measure the change in blood sugar levels
- Secondary Outcome Measures
Name Time Method Dosage of Insulin 4 weeks Measure the levels of insulin
Trial Locations
- Locations (1)
Avera Research Institute
🇺🇸Sioux Falls, South Dakota, United States